Li Fraumeni Syndrome
Li-Fraumeni syndrome (LFS) is a hereditary cancer syndrome caused by germline variants in the TP53 gene. It is seen in 1 in 5000 people worldwide
The most widely used criteria for determining who should undergo germline TP53 testing are the modified Chompret criteria.
1. Modified Chompret criteria
Genetic testing should be offered when a patient meets any one of the following criteria:
A. Cancer plus family history
Patient has an LFS-spectrum tumor diagnosed before age 46.
At least one first- or second-degree relative has an LFS-spectrum tumor before age 56, or has multiple tumors at any age.
If the relative has multiple tumors, breast cancer alone does not satisfy that particular multiple-tumor condition.
LFS-spectrum tumors include breast cancer, soft-tissue sarcoma, osteosarcoma, CNS tumors, and adrenocortical carcinoma.
B. Multiple primary cancers
Patient has at least two primary tumors, excluding multiple breast tumors.
At least two tumors are within the LFS spectrum.
The first cancer occurred before age 46.
C. Specific rare cancers, regardless of family history
Adrenocortical carcinoma
Choroid plexus carcinoma
Embryonal anaplastic rhabdomyosarcoma
D. Very early breast cancer
- Breast cancer diagnosed before age 31, regardless of family history.
Li-Fraumeni Syndrome (TP53): Recommended Cancer Screening Protocol
Screening Test | Starting Age | Frequency |
Whole-body MRI | Birth | Annually |
Brain MRI | Birth | Annually |
Complete physical examination | Birth | Every 3–4 months |
Abdominal/pelvic ultrasound | Birth | Every 3–4 months |
Adrenal hormone testing* | Birth | Every 3–4 months* |
CBC with differential* | Birth | Every 3–4 months* |
Breast MRI (women) | Age 20 | Annually |
Clinical breast examination | Age 20 | Every 6 months |
Colonoscopy | Age 25 or 5 years before earliest family diagnosis | Every 2–5 years |
Upper endoscopy | Age 25 or 5 years before earliest family diagnosis | Every 2–5 years |


Comments